| Home > Authorities > Institutes > Record #132915 |
Brainbank (Bonn)
Brainbank Unit Bonn Also known as:Brainbank Bonn| ID | I:(DE-2719)1011009 |
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |
Journal Article/Contribution to a conference proceedings
EPID-04. CAUSES AND LONG-TERM COURSE OF OTOTOXICITY IN PEDIATRIC MEDULLOBLASTOMA AND EPENDYMOMA PATIENTS – CUMULATIVE PLATINUM AND COCHLEAR IRRADIATION DOSE MATTER
2024 International Symposium on Pediatric Neuro-Oncology, ISPNO, Philadelphia, PAPhiladelphia, PA, USA, 29 Jun 2024 - 2 Jul 2024
Neuro-Oncology 26(Supplement_4), 0 (2024) [10.1093/neuonc/noae064.236]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent magnetic resonance imaging lesions after first-line treatment.
Neuro-Oncology 26(9), 1712 - 1722 (2024) [10.1093/neuonc/noae071]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article (Review Article)
Pineal anlage tumor: clinical and diagnostic features, and rationales for treatment.
Journal of neuro-oncology 166(2), 359 - 368 (2024) [10.1007/s11060-023-04547-5]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Risk factors for domain-specific neurocognitive outcome in pediatric survivors of a brain tumor in the posterior fossa-Results of the HIT 2000 trial.
Neuro-Oncology 26(11), 2113 - 2124 (2024) [10.1093/neuonc/noae092]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Clinical and molecular characterization of isolated M1 disease in pediatric medulloblastoma: experience from the German HIT-MED studies.
Journal of neuro-oncology 157(1), 37 - 48 (2022) [10.1007/s11060-021-03913-5]
Files
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study.
Neuro-Oncology 23(9), 1597 - 1611 (2021) [10.1093/neuonc/noab136]
Fulltext by Pubmed Central
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Quality assurance in neuropathology: Experiences from the round robin trials on IDH mutation and MGMT promoter methylation testing launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019
Clinical neuropathology 39(09), 203 - 211 (2020) [10.5414/NP301278]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort
Journal of clinical oncology 38(18), 2028 - 2040 (2020) [10.1200/JCO.19.03057]
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
Mutated SON putatively causes a cancer syndrome comprising high-risk medulloblastoma combined with café-au-lait spots.
Familial cancer 18(3), 353-358 (2019) [10.1007/s10689-019-00121-z]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
Journal Article
[Neuropathology of medulloblastomas and other CNS embryonal tumors : Precision diagnostics through the integration of genetic markers].
Der Pathologe 40(2), 140-147 (2019) [10.1007/s00292-019-0580-9]
Files
BibTeX |
EndNote:
XML,
Text |
RIS
All known publications ...
Download: BibTeX | EndNote XML, Text | RIS |